New brain cancer treatment trial seeks to extend survival
NCT ID NCT04752813
Summary
This study is testing whether adding an experimental drug called BPM31510 to standard radiation and chemotherapy can help people with newly diagnosed glioblastoma, an aggressive brain cancer. The main goal is to see if this combination can delay cancer progression and extend survival. About 50 participants will receive the experimental treatment alongside standard care to evaluate safety and effectiveness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cedars-Sinai Medical Center
Los Angeles, California, 90048, United States
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Inova
Fairfax, Virginia, 22037, United States
-
Mount Sinai Hospital
New York, New York, 10029, United States
-
Sansum Clinic
Santa Barbara, California, 93105, United States
-
Stanford University Cancer Center
Palo Alto, California, 94305, United States
-
Texas Oncology
Austin, Texas, 78705, United States
-
UT Health San Antonio Mays Cancer Center
San Antonio, Texas, 78229, United States
-
Valley Health
Ridgewood, New Jersey, 07450, United States
-
Virginia Cancer Specialists
Fairfax, Virginia, 22031, United States
-
Virginia Oncology Associates
Norfolk, Virginia, 23502, United States
Conditions
Explore the condition pages connected to this study.